Leadership
Our leaders bring passion, perspective, expertise and focus to their roles to forge a healthy future for all.
“Many of us at Acadia have first-hand experience with loved ones impacted by the challenges of the diseases we aim to treat. We are connected by a shared passion to break through these challenges and fight for the lives of the people we serve.”
Management Team
Steve Davis
Chief Executive Officer
Serge Stankovic
President
Austin Kim
Executive Vice President, General Counsel and Secretary
Mark Schneyer
Executive Vice President, Chief Financial Officer
Brendan Teehan
Executive Vice President, Chief Operating Officer, Head of Commercial
Rob Ackles
Senior Vice President, Chief People Officer
Kathie Bishop
Senior Vice President, Head of Rare Disease and External Innovation
Daryl DeKarske
Senior Vice President, Global Head of Regulatory Affairs and Head of Translational Sciences
Julie Fisher
Senior Vice President, Marketing and Commercial Strategy
Bob Mischler
Senior Vice President, Strategy and Technology Operations
Parag Meswani, Pharm.D
Senior Vice President, Trofinetide – Rare Disease Franchise
Sanjeev Pathak
Senior Vice President, Head of Clinical Development
Ponni Subbiah
Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer
Mary Ellen Turner
Senior Vice President, Pharmacovigilance and Corporate Safety Officer
Holly Valdiviez
Senior Vice President, Head of Sales
Board of Directors
Featured Perspectives
From triumphs to challenges, we are promoting perspectives and driving discussion around the latest neuroscience topics. Read our insights and join the conversation.
